Hypertension Trial, Recruiting (NCT06123377)

Hypertension Trial, Recruiting NCT06123377 Sponsor: Saint Thomas Hospital, Panama Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06123377 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Pregnant women who are between 24 and 40 weeks pregnant
People who have been diagnosed with gestational hypertension (high blood pressure that develops during pregnancy) according to standard medical guidelines
People whose blood test shows a specific protein ratio (called sFlt-1/PlGF) at or below 33, which is used to assess pregnancy-related complications (confirm with trial site)

Who may not be able to join:

People who are pregnant with more than one baby (such as twins or triplets)
People who have a condition called vasculitis, which involves inflammation of the blood vessels
People who have had three or more previous caesarean section births
People who have a neurological condition (a condition affecting the brain or nervous system)
People who have chronic kidney disease
People who have purpura (a condition that causes purple-coloured spots on the skin due to bleeding under the skin)
People who have a heart condition
People whose blood test shows the specific protein ratio (sFlt-1/PlGF) is 34 or higher

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +507 65655041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06123377

Sponsor: Saint Thomas Hospital, Panama

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +507 65655041

More information: https://clinicaltrials.gov/study/NCT06123377

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Pregnant women who are between 24 and 40 weeks pregnant
People who have been diagnosed with gestational hypertension (high blood pressure that develops during pregnancy) according to standard medical guidelines
People whose blood test shows a specific protein ratio (called sFlt-1/PlGF) at or below 33, which is used to assess pregnancy-related complications (confirm with trial site)

Who may not be able to join:

People who are pregnant with more than one baby (such as twins or triplets)
People who have a condition called vasculitis, which involves inflammation of the blood vessels
People who have had three or more previous caesarean section births
People who have a neurological condition (a condition affecting the brain or nervous system)
People who have chronic kidney disease
People who have purpura (a condition that causes purple-coloured spots on the skin due to bleeding under the skin)
People who have a heart condition
People whose blood test shows the specific protein ratio (sFlt-1/PlGF) is 34 or higher

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Saint Thomas Hospital, Panama

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

15 August 2026

Where this trial is recruiting

Panama

Primary endpoints

Progression to preeclampsia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov